enamel
发表于 2025-3-21 19:08:55
书目名称Entry Inhibitors in HIV Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0311883<br><br> <br><br>书目名称Entry Inhibitors in HIV Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0311883<br><br> <br><br>
BLOT
发表于 2025-3-21 21:47:52
http://reply.papertrans.cn/32/3119/311883/311883_2.png
时代
发表于 2025-3-22 03:46:00
http://reply.papertrans.cn/32/3119/311883/311883_3.png
墙壁
发表于 2025-3-22 04:52:55
http://reply.papertrans.cn/32/3119/311883/311883_4.png
CREEK
发表于 2025-3-22 09:48:42
Inhibitors that target gp120 interactions with coreceptor,ssays on human cell lines as syncytium inducing (SI) or non-syncytium inducing (NSI) [.]. NSI viruses predominate early after transmission, are capable of growth in primary macrophages (macrophage tropism), and fail to grow in most established human T cell lines. SI viruses, by contrast, are found i
半球
发表于 2025-3-22 16:28:23
http://reply.papertrans.cn/32/3119/311883/311883_6.png
半球
发表于 2025-3-22 19:24:50
Entry inhibition of HIV-1 subtype C isolates, [.]. There is less information on how genetic variability might affect the efficacy of a newer class of anti-retrovirals, the entry or fusion inhibitors. This group comprises a diverse collection of compounds that target both viral and host cell components blocking virus attachment and/or fusion an
PACK
发表于 2025-3-22 21:36:39
http://reply.papertrans.cn/32/3119/311883/311883_8.png
重画只能放弃
发表于 2025-3-23 01:31:01
Future clinical prospects for entry inhibitors,once (with the FDA approval of a membrane fusion inhibitor, enfuvirtide, in 2003) has this strategic approach resulted in a commercially available agent. Indeed, for more than 15 years, from 1987 to 2003, all available antiretroviral therapies targeted one of two HW-encoded enzymes, reverse transcri
Obsessed
发表于 2025-3-23 08:02:35
http://reply.papertrans.cn/32/3119/311883/311883_10.png